Testimony before the Vermont Senate Committee on Health and Welfare
Wednesday February 18th, 2009Sharon Treat
Senator Douglas Racine
Chair, Senate Committee on Health and Welfare
Re: Testimony on J.R.S. 18 - Joint resolution relating to prescription drug pricing (Senator Mullin)
Dear Senator Racine and Members of the Senate Committee on Health and Welfare:
Good afternoon and thank you for the invitation to testify before your Committee concerning Senator Mullin’s Joint resolution on drug pricing.
I am Sharon Treat, a Maine State Representative and Executive Director of the National Legislative Association on Prescription Drug Prices (NLARx), a nonprofit, nonpartisan organization of state legislators who network across state lines to find ways to reduce prescription drug costs and expand access to medicines. We’re pleased to include the Vermont Legislature as one of our earliest and most active members. Senator Mullin has been a leader on prescription drug issues for many years and currently serves as Vice Chair of our board.
J.R.S. 18 has six specific recommendations, (which I will list here out of the order they are drafted in the Resolution so that I can group into broader subject categories):
For more information: